Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Biophytis stock

Learn how to easily invest in Biophytis stock.

Biophytis is a biotechnology business based in the US. Biophytis shares (BPTS) are listed on the NASDAQ and all prices are listed in US Dollars. Biophytis employs 26 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Biophytis

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BPTS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Biophytis stock price (NASDAQ: BPTS)

Use our graph to track the performance of BPTS stocks over time.

Biophytis shares at a glance

Information last updated 2022-06-24.
Latest market close$1.09
52-week range$0.94 - $10.99
50-day moving average $1.41
200-day moving average $4.25
Wall St. target price$15.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.78

Buy Biophytis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biophytis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biophytis price performance over time

Historical closes compared with the close of $1.09 from 2022-07-01

1 week (2022-06-24) 0.93%
1 month (2022-06-03) -4.39%
3 months (2022-04-01) -50.00%
6 months (2022-01-03) -79.59%
1 year (2021-07-02) -88.85%
2 years (2020-06-29) N/A
3 years (2019-06-29) N/A
5 years (2017-06-29) N/A

Biophytis financials

Gross profit TTM $0
Return on assets TTM -52.81%
Return on equity TTM -783.82%
Profit margin 0%
Book value $0.42
Market capitalisation $18.5 million

TTM: trailing 12 months

Biophytis share dividends

We're not expecting Biophytis to pay a dividend over the next 12 months.

You may also wish to consider:

Biophytis share price volatility

Over the last 12 months, Biophytis's shares have ranged in value from as little as $0.94 up to $10.99. A popular way to gauge a stock's volatility is its "beta".

BPTS.US volatility(beta: 1.42)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biophytis's is 1.4205. This would suggest that Biophytis's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Biophytis's beta into context you can compare it against those of similar companies.

Biophytis overview

Biophytis S. A. , a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD.

Frequently asked questions

What percentage of Biophytis is owned by institutions?
Currently 1.507% of Biophytis shares are held by institutions.
How many people work for Biophytis?
Latest data suggests 26 work at Biophytis.
When does the fiscal year end for Biophytis?
Biophytis's fiscal year ends in December.
Where is Biophytis based?
Biophytis's address is: Sorbonne University, Paris, France, 75005
What is Biophytis's ISIN number?
Biophytis's international securities identification number is: US09076G1040

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site